TAH2231
Opioid overdose reversal (Naloxone)
Phase 1/2Active
Key Facts
About TAHO Pharmaceuticals
TAHO Pharma delivers novel transdermal and oral‑film drug formats to address unmet patient needs across cardiovascular, neurology, and oncology markets.
View full company profile